Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical goods.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Revenue | 6,650 | 2,943 | -55.8% |
| Total COGS | 2,437 | 1,154 | -52.6% |
| Gross Profit | 4,213 | 1,789 | -57.5% |
| Gross Margin | 63.4% | 60.8% | |
| 96 | 130 | +36.2% | |
| EBITDA | 4,117 | 1,658 | -59.7% |
| EBITDA Margin | 61.9% | 56.4% | |
| Total D&A | 0 | 0 | |
| EBIT / Operating Income | 4,117 | 1,658 | -59.7% |
| Total Interest Income | 0 | 1 | +294.1% |
| Total Other Income | 65 | 102 | +57.2% |
| Profit Before Tax | 4,182 | 1,761 | -57.9% |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 4,182 | 1,761 | -57.9% |
| Net Margin | 62.9% | 59.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →